| John Bourke Raff, MD | |
|
1506 Aston Ave, Mccomb, MS 39648-2735 | |
| (601) 249-4282 | |
| (601) 249-4852 |
| Full Name | John Bourke Raff |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 44 Years |
| Location | 1506 Aston Ave, Mccomb, Mississippi |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1194768994 | NPI | - | NPPES |
| 08585290 | Medicaid | MS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | MD025787 (Tennessee) | Secondary |
| 207X00000X | Orthopaedic Surgery | 19880 (Mississippi) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Memorial Hospital At Gulfport | Gulfport, MS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Memorial Hospital At Gulfport | 2466524012 | 376 |
News Archive
The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.
Mitt Romney's conservative credentials on birth control are examined through the lens of a Massachusetts state law similar to the birth control mandate President Obama has proposed. In other campaign news, Rick Santorum continues his "Romneycare" assault, and The Associated Press analyzes how Obama's birth control compromise affects the campaign.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement
Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.
Over 170,000 Canadians, many of them survivors, ran, walked, cheered or volunteered today as part of the largest single-day, fundraising event for breast cancer in Canada. The Run – in its 13th year – raised $19.2 million to boost breast cancer research and programs.
› Verified 4 days ago
| Entity Name | Memorial Hospital At Gulfport |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1215546635 PECOS PAC ID: 2466524012 Enrollment ID: O20090515000396 |
News Archive
The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.
Mitt Romney's conservative credentials on birth control are examined through the lens of a Massachusetts state law similar to the birth control mandate President Obama has proposed. In other campaign news, Rick Santorum continues his "Romneycare" assault, and The Associated Press analyzes how Obama's birth control compromise affects the campaign.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement
Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.
Over 170,000 Canadians, many of them survivors, ran, walked, cheered or volunteered today as part of the largest single-day, fundraising event for breast cancer in Canada. The Run – in its 13th year – raised $19.2 million to boost breast cancer research and programs.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| John Bourke Raff, MD 4500 13th St, Gulfport, MS 39501-2515 Ph: (601) 249-4282 | John Bourke Raff, MD 1506 Aston Ave, Mccomb, MS 39648-2735 Ph: (601) 249-4282 |
News Archive
The final results of the randomized phase two trial E3311 will be presented at the American Society of Clinical Oncology annual meeting, to occur virtually from May 29-31.
Mitt Romney's conservative credentials on birth control are examined through the lens of a Massachusetts state law similar to the birth control mandate President Obama has proposed. In other campaign news, Rick Santorum continues his "Romneycare" assault, and The Associated Press analyzes how Obama's birth control compromise affects the campaign.
miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and t2cure, a clinical stage biopharmaceutical company developing progenitor cell-based regenerative therapeutics for cardiac or peripheral vascular diseases, announced today that they have entered into a licensing agreement
Scientists at the Salk Institute for Biological Studies have identified a protein that drives the formation of pituitary tumors in Cushing's disease, a development that may give clinicians a therapeutic target to treat this potentially life-threatening disorder.
Over 170,000 Canadians, many of them survivors, ran, walked, cheered or volunteered today as part of the largest single-day, fundraising event for breast cancer in Canada. The Run – in its 13th year – raised $19.2 million to boost breast cancer research and programs.
› Verified 4 days ago
Dr. Gabriel S Salzman, M.D. Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1506 Aston Ave, Mccomb, MS 39648 Phone: 601-249-4282 | |
Dr. Bryan G Frentz, M.D. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 300 Rawls Dr Ste 500, Mccomb, MS 39648 Phone: 601-249-4282 Fax: 601-249-4852 |